Liu Yumeng, Feng Qiwen, Zou Liping, Zhu Changhong, Xia Wei
Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Andrology. 2024 Oct 22. doi: 10.1111/andr.13786.
Oligoasthenozoospermia is a common cause of male infertility, for which effective treatments are urgently needed. Humanin (HN) is a peptide associated with this condition.
To investigate the ameliorative effect of [Gly14]-Humanin (HNG) on oligoasthenozoospermia and the mechanisms.
Mice were treated with cyclophosphamide (CP) to construct a mice model of oligoasthenozoospermia. The resulting model mice were treated with saline or HNG. Subsequently, the testis weights, organ indices, testicular structure, sperm counts and motilities, litter sizes, and serum testosterone concentrations of the mice were determined. Differential gene expression in testicular tissues was determined by RNA sequencing. TM3, TM4, GC1, and GC2 cells were exposed to erastin to induce ferroptosis, followed by treatment with HNG or HNG + ML385 (a nuclear factor erythroid 2-related factor 2 inhibitor). Levels of reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), and ferrous ions (Fe) were determined and their expression of ferroptosis-related proteins was determined by immunofluorescence and western blot.
The HNG treatment improved testis and sperm parameters and increased litter size and serum testosterone concentrations in model mice. Kyoto Encyclopaedia of Genes and Genomes pathway enrichment analysis revealed significant differential expression of ferroptosis-related genes. The expression of ferroptosis-related proteins increased in testicular tissues after the HNG treatment. The concentrations of ROS, MDA, and Fe decreased and the concentrations of GSH increased in testicular tissues and in TM3 and TM4 cells after HNG treatment. In vitro experiments confirmed that HNG activated the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 (Nrf2/GPX4) pathway. However, these effects of HNG were blocked by ML385 treatment.
HNG demonstrated a therapeutic effect on oligoasthenozoospermia in a mouse model by reducing oxidative stress and ferroptosis. In TM3 and TM4 cells, HNG attenuated cellular oxidative stress and inhibited ferroptosis via the Nrf2/GPX4 pathway.
少弱精子症是男性不育的常见原因,迫切需要有效的治疗方法。人胰岛素(HN)是与这种情况相关的一种肽。
研究[Gly14]-人胰岛素(HNG)对少弱精子症的改善作用及其机制。
用环磷酰胺(CP)处理小鼠以构建少弱精子症小鼠模型。将所得模型小鼠用生理盐水或HNG处理。随后,测定小鼠的睾丸重量、器官指数、睾丸结构、精子数量和活力、产仔数以及血清睾酮浓度。通过RNA测序确定睾丸组织中的差异基因表达。将TM3、TM4、GC1和GC2细胞暴露于埃拉司亭以诱导铁死亡,然后用HNG或HNG + ML385(一种核因子红细胞2相关因子2抑制剂)处理。测定活性氧(ROS)、丙二醛(MDA)、谷胱甘肽(GSH)和亚铁离子(Fe)的水平,并通过免疫荧光和蛋白质印迹法测定其铁死亡相关蛋白的表达。
HNG处理改善了模型小鼠的睾丸和精子参数,并增加了产仔数和血清睾酮浓度。京都基因与基因组百科全书通路富集分析显示铁死亡相关基因存在显著差异表达。HNG处理后睾丸组织中铁死亡相关蛋白的表达增加。HNG处理后,睾丸组织以及TM3和TM4细胞中ROS、MDA和Fe的浓度降低,GSH的浓度增加。体外实验证实HNG激活了核因子红细胞2相关因子2/谷胱甘肽过氧化物酶4(Nrf2/GPX4)通路。然而,ML385处理阻断了HNG的这些作用。
HNG通过降低氧化应激和铁死亡对小鼠模型中的少弱精子症具有治疗作用。在TM3和TM4细胞中,HNG通过Nrf2/GPX4通路减轻细胞氧化应激并抑制铁死亡。